glucose, (beta-d)-isomer has been researched along with sergliflozin etabonate in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujikura, H; Fujimori, Y; Hiratochi, M; Isaji, M; Itoh, F; Katsuno, K; Komatsu, Y; Takemura, Y | 1 |
| Isaji, M | 1 |
| Goldstein, BJ; Jabbour, SA | 1 |
| Fujimori, Y; Isaji, M; Ishikawa-Takemura, Y; Katsuno, K; Kusama, H; Nakano, S; Nakashima, I; Ojima, K | 1 |
| Fujimori, Y; Isaji, M; Ishikawa-Takemura, Y; Katsuno, K | 1 |
| Amin, DM; Clark, RV; Dobbins, RL; Hussey, EK; Kipnes, MS; Layko, D; Leong, J; Murray, SC; Nunez, DJ; O'Connor-Semmes, RL; O'Driscoll, EC | 1 |
| Dobbins, RL; Hussey, EK; Kapur, A; Layko, D; Murray, SC; Nunez, DJ; O'Connor-Semmes, RL; Stockman, NL; Stoltz, RR | 1 |
| Sharma, K; Vallon, V | 1 |
| Chan, JY; Lau, CB; Ng, WL; Shing, TK | 1 |
| Babu, RJ; Dash, RP; Srinivas, NR | 1 |
4 review(s) available for glucose, (beta-d)-isomer and sergliflozin etabonate
| Article | Year |
|---|---|
Sodium-glucose cotransporter inhibitors for diabetes.
Topics: Animals; Carbonates; Clinical Trials, Phase II as Topic; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypoglycemic Agents; Molecular Structure; Sodium-Glucose Transport Proteins | 2007 |
Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors | 2008 |
Sodium-glucose transport: role in diabetes mellitus and potential clinical implications.
Topics: Absorption; Benzhydryl Compounds; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucose; Glucosides; Humans; Kidney; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2010 |
Comparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview.
Topics: Blood Glucose; Bridged Bicyclo Compounds, Heterocyclic; Diabetes Mellitus, Type 2; Glucosides; Half-Life; Humans; Hypoglycemic Agents; Pyrazoles; Sodium-Glucose Transporter 2 | 2017 |
2 trial(s) available for glucose, (beta-d)-isomer and sergliflozin etabonate
| Article | Year |
|---|---|
Single-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy volunteers and patients with type 2 diabetes mellitus.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Monitoring; Female; Glucose; Glucosides; Glycosuria; Humans; Hypoglycemic Agents; Male; Middle Aged; Prodrugs; Water-Electrolyte Balance | 2010 |
Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study.
Topics: Adolescent; Adult; Benzhydryl Compounds; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Drug Monitoring; Female; Glucosides; Glycosuria; Half-Life; Humans; Insulin; Male; Middle Aged; Obesity; Overweight; Prodrugs; Water-Electrolyte Balance | 2010 |
4 other study(ies) available for glucose, (beta-d)-isomer and sergliflozin etabonate
| Article | Year |
|---|---|
Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level.
Topics: Absorption; Animals; Blood Glucose; Dogs; Electrolytes; Erythrocytes; Female; Glucose; Glucose Tolerance Test; Glucosides; Glycosuria; Hypoglycemic Agents; Kidney; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2007 |
Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats.
Topics: Animals; Area Under Curve; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fasting; Glucose Tolerance Test; Glucosides; Glycated Hemoglobin; Glycosuria; Hypoglycemic Agents; Insulin; Kinetics; Male; Rats; Rats, Zucker; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2009 |
Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A(y) mice.
Topics: Administration, Oral; Animals; Benzhydryl Compounds; Drug Administration Schedule; Female; Glucose; Glucosides; Hyperinsulinism; Hypoglycemic Agents; Mice; Mice, Inbred Strains; Obesity; Time Factors | 2009 |
Design, syntheses, and SAR studies of carbocyclic analogues of sergliflozin as potent sodium-dependent glucose cotransporter 2 inhibitors.
Topics: Glucosides; Humans; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Structure-Activity Relationship | 2013 |